Transducin-like Enhancer Protein 4 (TLE4) (N-Term) Peptide
TLE4
Reactivity: Human
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN985128
Quick Overview for Transducin-like Enhancer Protein 4 (TLE4) (N-Term) Peptide (ABIN985128)
Target
TLE4
(Transducin-like Enhancer Protein 4 (TLE4))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-TLE4 antibody (Catalog #: ARP32381_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TLE4 (Transducin-like Enhancer Protein 4 (TLE4))
-
Background
-
TLE4 is the transcriptional corepressor that binds to a number of transcription factors. It inhibits the transcriptional activation mediated by PAX5, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES.
Alias Symbols: BCE-1, E(spI), ESG, ESG4, GRG4, BCE1
Protein Interaction Partner: MSX1,OTX1,OTX2,PAX5,POU2F1,TLE4,HDAC1,PAX5
Protein Size: 773 -
Molecular Weight
- 84 kDa
-
Gene ID
- 7091
-
NCBI Accession
- NM_007005, NP_008936
-
UniProt
- Q04727
Target
-
You are here:
